Simon May, Former Bio-Rad EVP and President of Life Sciences Group, Joins Agilent as President of Diagnostics and Genomics Group
Bio-Rad
Developer of Life Science and Clinical Diagnostic Products
Thermo Fisher Scientific
Biotechnology Product Developer
Santa Clara, California, April 29, 2024 – Agilent Technologies, Inc. (NYSE: A)Today, it was announced that Simon May has been appointed as the President of the company's Diagnostic and Genomics Group (DGG).Simon May previously served as Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc., and will join Agilent Technologies (China) Co., Ltd. on May 6.
Simon May, President of Agilent Diagnostics and Genomics Group
Agilent Chief Operating Officer and Incoming Chief Executive Officer Padraig McDonnell said:
“We are very pleased and welcome Simon May to join the Agilent team.Simon's deep technical knowledge, extensiveHis experience and focus on strategy, continuous improvement, and operational excellence throughout his career are important additions to our DGG Group's active pursuit of current opportunities and our commitment to helping customers turn great science into reality.。”
Before serving as Executive Vice President of Bio-Rad and President of the Life Science Group, Simon May held other key positions at the company, including Senior Vice President and General Manager of the Digital Biology Group, and Senior Vice President of Global Commercial Operations. Prior to joining Bio-Rad in 2014, Simon May worked for Thermo Fisher Scientific for 10 years and also served at MWG Biotech. His career began in a laboratory role, followed by progression into sales, product management, and business leadership positions.
Simon May obtained his bachelor's and doctoral degrees in Genetics/Molecular Biology from the University of Liverpool, UK, and subsequently served as a postdoctoral researcher at the same institution for two years.
Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, committed to providing sharp insights and innovative expertise to improve the quality of human life. Agilent's instruments, software, services, solutions, and experts offer more reliable answers to customers' most challenging problems. In fiscal year 2023, Agilent generated revenue of $6.83 billion and employed 18,000 people worldwide.
---The End---
If you like it, just one-click triple action: like, favorite, and share.！